Acura Accused Of Securities Fraud Over Acurox
A shareholder has launched a putative class action against Acura Pharmaceuticals Inc., accusing the pharmaceutical research company of misleading investors about the ability of its lead product, the painkiller Acurox, to...To view the full article, register now.
Already a subscriber? Click here to view full article